The market is projected to reach USD 564.4 Million in 2025 and is expected to grow to USD 1,477.2 Million by 2035, registering a CAGR of 10.1% over the forecast period. The expansion of fertility clinics, increasing government support for IVF treatments, and advancements in cryoprotectant formulations are fueling market expansion. Additionally, growing awareness of fertility preservation, rising demand for egg freezing among career-focused individuals, and innovations in automated cryo storage systems are shaping the industry's future.
From the year 2025 through 2035, the market for cryopreservation of embryos for IVF is expected to grow rapidly on a number of different fronts, this including the fact that numbers d infertility are rising, a growing consciousness about fertility preservation and improvements in assisted reproductive technology (ART).Increasing infertility levels worldwide are the result of globalization, delayed child-bearing, lifestyle transformations and environmental stressors (for example metropolitan air pollution from the gridlock of cars). Thus, there is a growing need for effective treatments of reproductive disorders.
Cryopreservation is now an integral part of ART that enables reproductive cells such as embryos, oocytes and sperm to be stored for the long term. This helps improve the success rate of IVF procedures. Keeping in the way of innovative cryopreservation methods especially vitrification greatly enhances preservative cell survival rates, reduces ice crystal formation, t and damage to the cell also gets minimized. This has brought about higher rates of implantation success and the patient's confidence in IVF treatment has increased.
Market Metrics
| Metric | Value |
|---|---|
| Market Size (2025E) | USD 564.4 Million |
| Market Value (2035F) | USD 1,477.2 Million |
| CAGR (2025 to 2035) | 10.1% |
The increasing acceptance of the therapies known as fertility preservation is designed to safeguard reproductive health. It is creating yet another demand for this market. By preserving their fertility at the most appropriate time, cryopreservation allows individuals greater freedom in planning parenthood; an option that is in line with current trends to put off childbearing.
Diverse countries have set up cyopreservation research bases and as a result various efforts to contribute crpopreservation technology are under way. Simultaneously, favorable regulation and government initiatives in many areas support and foster such investment.
The growing number of fertility clinics and the expansion of IVF are also boosting the market. Both established and emerging countries take part in this activity, so their demands are high. All modern fertilization systems do this, although their efficiency may differ. The market should witness another burst of activity as better and better fertilization methods are provided for an increasingly diverse patient population.
Explore FMI!
Book a free demo
Cryopreservation for IVF is a market in which North America is set to remain the primary location GeneOn China) Harry Wang HARRY.WANG New Crest researchers predict that The area has high adoption rates for ART, many fertility clinics are located there and also about cryogenic storage solutions have been developed locally.
Moreover, the region is even forecast to account for larger than its historical share of growth.Canada and the United States lead in this region as a result of increased awareness among people regarding egg and embryo freezing. The insurance solution for fertility treatment is quite good. Some investors have placed startups offering artificial intelligence-assisted embryo selection into practice.
The American Society for Reproductive Medicine (ASRM) guidelines supporting oocyte cryopreservation for medical and elective fertility preservation are further speeding the market's growth. In addition, the integration of robotic cryopreservation systems and blockchain-based fertility data tracking is both increasing storage security levels and providing success ratios.
When it comes to Cryopreservation for IVF Market, Europe accounts for a considerable share of the market. These countries are all at the forefront in state-funded programs of assisted reproductive technology (ART)(Assisted Reproductive Technology) maker donor eggs seem urgent and freezing embryos to store them for future fashion applications is also on the rise.
Europe has long used Cong Jie as a time to widely carry out cryopreservation of eggs and embryos, and this market growth is now driving that expansion. Plus, ever-higher investments in cryobank hardware, stricter regulations (such as the ban on solo-womb storage introduced by Congress in 2011), and popularity of cross-border reproductive care (CBRC) reshaping the market.
Driven by ever higher infertility rates, government programs to increase fertility among its citizens, and ART - orientated medical tourism powered by insurance companies the Asia - Pacific region will become one of the few places in our ageing world where remaining at work and having children are not mutually exclusive.
China, Japan, India and South Korea are taking the lead in IVF treatment extension, further development of in vivo storage technology and increasing requests by females wishing to postpone having children indefinitely for fertility preservation.
As it relaxes its birth policies, China sees increasing demand for egg freezing and embryo storage services due to ART funding. In addition, India's cost-effective ART treatment and rapidly spreading network of fertility clinics has made it the focus of tourism in this medical area. Japan and South Korea, on the other hand, have taken another road. They are putting more money into creating AI-driven embryo grading tools and automated cryopreservation systems to stimulate market acceptance.
Challenges
High Costs and Ethical Concerns
Cold storage, longterm storage and advanced vitrification methods are the subject of one of the main problems confronting Cryopreservation For IVF market. Many fertility treatments are not affordable even in the more developed regions because most insurance providers provide limited coverage and labs take a lot of maintenance costs.
Furthermore, ethical questions arise about storing embryos cryogenically for long periods, and disputes over embryo ownership, and dispose responsibilities present challenges for both clinics and regulatory bodies. The market is also affected by the absence of any set protocols for shipping cryopreserved gametes and secure storage of goods.
Opportunities
AI-Powered Embryo Selection and Expansion of Fertility Preservation Services
Despite challenges, the Cryopreservation for IVF Market presents significant growth opportunities. The artificial-intelligence based embryo-selection, along with predictive analytics for IVF success rates for silicon embryos, and a cryo-storage monitoring system based on automated processing are all contributing to improved efficiency and results.
Cancer patients undergoing chemotherapy, transgender individuals, and women who delay childbearing are seeking preservation of fertility that includes egg, sperm or embryo freezing services. Fertility management innovation based on nanotechnology complex cryoprotectants and fast vitrification technology through high-throughput vitrification techniques are presents an opportunity for IVF clinics along with cryobanks. With the rise of new ventures centered on fertility, mobile applications targeting this market and more conventional cryopreservation services, patient reach is being enhanced in real time.
It will be in niche markets and in countries with relatively loose restrictions on ART, such as certain Latin American countries or the Middle East, that future growth possibilities lie. If you include this with rising awareness of fertility treatments, it could translate to a further boost for businesses offering services related to cryopreservation.
Between 2020 and 2024, the cryopreservation for in-vitro fertilization (IVF) market experienced significant growth, driven by rising infertility rates, increasing acceptance of assisted reproductive technologies (ART), and advancements in cryogenic storage solutions.
The growing trend of delayed parenthood, increased demand for fertility preservation, and improved success rates in embryo freezing techniques contributed to market expansion. The widespread adoption of vitrification, slow freezing, and oocyte cryopreservation improved embryo viability and IVF success rates.
Between 2025 and 2035, the cryopreservation for IVF market will undergo transformative advancements with the rise of AI-powered cryo-monitoring, gene-editing-enhanced embryo preservation, and blockchain-backed fertility data security.
AI-driven real-time embryo viability analysis and automated cryogenic storage tracking will optimize frozen embryo selection and reduce cryo-storage risks. The emergence of lab-grown artificial gametes and stem cell-derived embryo generation will further revolutionize IVF treatment personalization and fertility preservation.
Market Shifts: A Comparative Analysis 2020 to 2024 vs. 2025 to 2035
| Market Shift | 2020 to 2024 |
|---|---|
| Regulatory Landscape | Compliance with FDA, ESHRE, and HFEA guidelines on embryo freezing, storage, and ethical IVF practices. |
| Technological Advancements | Growth in vitrification, AI-assisted embryo selection, and liquid nitrogen-based cryopreservation. |
| Industry Applications | Used in fertility clinics, reproductive biobanks, and personalized IVF treatments. |
| Adoption of Smart Equipment | Adoption of automated cryogenic storage, liquid nitrogen monitoring systems, and vitrification-enhanced freezing protocols. |
| Sustainability & Cost Efficiency | Transition to low-energy cryo-storage solutions, optimized nitrogen usage, and reduced cryo-wastage. |
| Data Analytics & Predictive Modeling | Use of basic embryo viability tracking, patient fertility history analytics, and real-time cryo-temperature monitoring. |
| Production & Supply Chain Dynamics | Challenges in cryogenic material sourcing, cryo-storage capacity limitations, and global fertility access disparities. |
| Market Growth Drivers | Growth fueled by delayed parenthood trends, rising IVF success rates, and growing ART accessibility. |
| Market Shift | 2025 to 2035 |
|---|---|
| Regulatory Landscape | Blockchain-secured fertility data storage, AI-powered cryopreservation risk assessment, and global fertility preservation policies. |
| Technological Advancements | Next-gen AI-powered embryo viability monitoring, synthetic gamete cryopreservation, and quantum-enhanced cryo-optimization. |
| Industry Applications | Expanded into AI-driven automated cryo-banking, longevity cryopreservation, and stem-cell-derived gamete freezing. |
| Adoption of Smart Equipment | IoT-based real-time cryo-monitoring, AI-integrated frozen embryo selection, and lab-grown embryo cryo-banking. |
| Sustainability & Cost Efficiency | Liquid nitrogen-free cryogenic storage, AI-powered cryo-energy efficiency, and eco-friendly cryo-preservation techniques. |
| Data Analytics & Predictive Modeling | AI-powered predictive embryo selection, blockchain-based fertility data security, and real-time adaptive cryo-condition adjustments. |
| Production & Supply Chain Dynamics |
Decentralized cryo-IVF biobanking, AI-driven fertility logistics optimization, and blockchain-verified cryopreservation records. |
| Market Growth Drivers | Future expansion driven by AI-enhanced cryo-IVF, regenerative cryobiology, and next-gen fertility bioengineering. |
With infertility rates and efforts to extend fertility both rising, Cryopreservation for In-vitro Fertilization (IVF) Market in the United States has seen a rapid increase. In addition, the continual improvement of cryopreservation technology has helped USA National Institute of Child Health & Human Development National Center for Medical Research in Maternal and Child Health develop a reference cryopreservation technique that chronicled over 17 common human tumors.
The USA Centers for Disease Control and Prevention and the American Society for Reproductive Medicine actively support assisted reproductive technologies including embryo and oocyte cryopreservation. This is key in helping people to have children of their own without begetting antisocial behavior patterns through intervention early on during childhood itself.
The move to provide more egg freezing services, advances in vitrification techniques, and AI-powered embryo selection make the outcome of IVF procedures better still. In addition, employer-sponsored fertility benefits as well as a rising need for social egg freezing cause the market to increase.
| Country | CAGR (2025 to 2035) |
|---|---|
| USA | 10.5% |
More and more people in UK are turning to the rather young but fast-expanding field of infertility research. This is partly because government support for fertility treatments has increased, while reproductive health issues are now much more publicly accepted in general. In vitro fertilization (IVF) and cryopreservation in The United Kingdom is supervised by the HFEA, so the standard for quality is very high as well as a strong sense of ethical responsibility.
With the increase in oncofertility (fertility preservation for cancer patients) and employer-sponsored IVF programs, there has been a boom in sperm, egg and embryo freezing services. The development of next-generation vitrification solutions and automatic cryopreservation systems has also given added impetus to innovation within this field.
| Country | CAGR (2025 to 2035) |
|---|---|
| UK | 9.8% |
Favorable healthcare policies, increasing investments in ART research, and rising demand for fertility preservation services are contributing to Europe's Cryopreservation for In-vitro Fertilization (IVF) market surge. Developing new scientific research methods in the field along with mainstreaming related technology are strengthening the European Society for Human Reproduction and Embryology (ESHRE)'s backing of IVF cryopreservation both steadily.
Germany, France, and Spain are leading the market, with government-funded fertility programs improving accessibility to cryopreservation services for medical and elective fertility preservation. Furthermore, new cryo-storage monitoring systems and AI-based embryo grading have furthered success rate in IVF treatments.
| Region | CAGR (2025 to 2035) |
|---|---|
| European Union (EU) | 10.1% |
The Cryopreservation for In-vitro Fertilization (IVF) Market in Japan is growing, partly because the government has begun to subsidize many types of fertility treatments. The average age for a Japanese mother is increasing every year, and more women are choosing to have their eggs frozen until later.
People seem to be more willing than ever before to freeze oocytes or sperm for later use. The Japanese Ministry of Health, Labour and Welfare (MHLW) has two financial support schemes in place specifically to encourage IVF and the preservation of fertility. As a result more and more couples are choosing cryopreservation with each passing year.
At Japanese fertility clinics, sophisticated vitrification techniques, state-of-the-art cryostorage systems, and the kind of technology for genetic screening that you would expect in a sci-fi movie are all helping to advance IVF outcomes. In addition, AI-driven reproductive health solutions are changing the way in which embryos are selected and stored.
| Country | CAGR (2025 to 2035) |
|---|---|
| Japan | 10.3% |
In the dawn of In-vitro Fertilization (IVF), South Korea's Cryopreservation for In-vitro Fertilization (IVF) Market is booming and seeing exponential growth in consumer demand, driven largely by government supported fertility policies and rising corporate insurance covers for ARTs as well as growing need to preserve fertility cells. The South Korean Ministry of Health and Welfare is energetically supporting egg-freezing services, embryo cryopreservation, and reproductive health research.
The growth of medical tourism for fertility treatments, breakthroughs in cryoprotectants and AI-assisted embryo analysis are expediting market expansion. Moreover, the integration of blockchain-based digital storage for frozen samples both enhances the security and transparency of these procedures.
| Country | CAGR (2025 to 2035) |
|---|---|
| South Korea | 10.6% |
The growing Cryopreservation for In-Vitro Fertilization (IVF) Market can be put down to rising infertility rates, demand for fertility preservation, progress in assisted reproductive technology (ART), and general awareness about egg embryo freezing. The cryopreserved products include media and equipment, boosting the market by ensuring cell viability for a long stretch as well as improved success rates in IVF.
Ice crystals and other types of cryo-induced injury destroy virtually every cell system, for this reason cryopreservation media are crucial. The reason these media solutions are successful is that they contain cryoprotectants such as dimethyl sulfoxide (DMSO), glycerol, and ethylene glycol (EG) to maintain cellular integrity and help cells survive after thawing.
The increasing demand for high-quality, chemically defined cryopreservation media is being met by the spread of vitrification-based techniques. Using freezing times faster than a flash of lightning, these afford the perfect combination of ultra-rapid freezing and ice crystal avoidance. Additionally, custom compositions of freezing and thawing media for specific cell types are increasing the success rates of IVF treatments.
Monitoring of cryopreserved embryos′ survival has shown that efficacy cannot be easily obtained. Nevertheless, despite existing challenges such as toxic effects of cryoprotectants and something called novel popular formulations, regulatory approvals do not stop this from happening. With advances in synthetic, serum-free, and low-toxicity cryoprotectants, we anticipate that greater cell viability can be achieved and there will be wider adoption for these fertile therapies.
As more and more IVF clinics and research laboratories are recognizing, cryopreservation devices, such as controlled-rate freezers and automated vitrification systems, can regulate cooling rates very precisely. This prevents thermal shock during the slow freeze process, thus increasing overall cell survival post-thaw-one of the biggest advantages of vitrifying embryos.
Soft embryos that are too weak for slow freezing can be cryopreserved in a vitreous form without suffering any damage. Vitrification may not always prove successful, but it is usually feasible in most instances.
These devices ensure consistent temperature control, and automation of freezing cycles as well as reproducibility in cryopreservation protocols; critical for massive fertility preservation programs. The integration of AI-driven cryopreservation technologies, remote monitoring systems, and automated liquid nitrogen-free storage solutions is driving demand for advanced freezing devices in IVF applications even higher. In addition, portable and compact cryopreservation units are extending fertility preservation services into new markets.
However, high costs, maintenance complexities, and stringent handling protocols bring challenges to broader adoption. Expectations are that cost-effective, energy-efficient cryopreservation devices with enhanced automation and digital integration will improve the efficiency and linear scalability of IVF cryopreservation, as well as the convenience of use.
The demand for cryopreservation solutions mainly comes from IVF & fertility hospitals and biobanks where frozen embryos, eggs, and sperm are stored for long term reproductive use as well as scientific research into fertility techniques.
IVF and the field of fertility are the primary users of cryopreservation techniques, procedures of embryos to frozen storage storage (FETS) and fertility preservation therapies have become a standard feature in assisted reproduction as part of its continued march towards excellence.
Clinics use cryopreservation techniques to improve the success rate for IVF cycles, cut down on multiple embryo transfers in preference of single transfer policy and provide a reproductive future for those cancer patients with childrens potential still ahead in life.
The more widespread approach to oocyte and embryo cryopreservation, the increasing number of egg freezing banks and trend for social egg freezing are driving demand for advanced cryopreservation media, devices and storage services. It is expected that pragmatic personalized fertility preservation strategies and AI powered embryo selection algorithms will further improve clinical decision making and success rates in fertility treatments.
The problems of high procedural costs, ethical dilemmas and differences in embryo survival rates still keep their head way into market expansion in this field happening. However, future improvements such as increased embryo cryotolerance and the use non-toxic cryprotectants for making embryo cryopreservation more non-damaging to embryos advanced thawing machines are likely meant at least some gains from this aspect of cryobiology shall derive in future treatments.
Biobanks and research institutes are significant because they keep reproductive cells when not needed for immediate parenthood; they use them in the scientific study of fertility as well as preserving genetically material for application to stem cells. To accomplish this goal these facilities feature large-scale long-term preservation systems for sperm, oocytes and embryos in extremely low temperature conditions that preserve genetic integrity over the ages.
Consequently, some particularly high-volume requirements in fertility preservation efforts aimed at using stem cells for reproduction and preimplantation genetic diagnosis (PGD) renew the market pressure on robots for liquid nitrogen storage facilities. Moreover, government-supported programs and plants for cryopreservation of reproduction cells are developing on a global scale.
At the same time, factors such as the demand for regulatory compliance, the risk of storage failure and the high cost of operations all reduce the ability to bring this innovation nationwide. Breakthroughs in cryogenic storage automation, AI-based inventory control across vast collections (e.g. thousands of frozen embryos) and technology to assess embryos' viability without damaging them through invasive observation are expected to raise productivity at biobanks. One finds it likely these methodologies will also shore up the system's long-term reliability.
Growing demand for assisted reproductive technology (ART), an apparent increase in infertility rates, and advances in cryopreservation techniques have all played their part in the Cryopreservation for In-Vitro Fertilization (IVF) market. Embryo and oocyte freezing are not well established in the field of fertility treatment, but these procedures have been made more common through some advances in vitrification as well as favorable regulatory approval for fertility preservation.
The corporations are focusing on high-viability cryoprotectants, freezing technologies with a closed system, and computerized solutions for cryogenic conservation to help achieve high IVF success rates, long-term storage, and accessibility for the patient. The ultra-low temperature storage market includes top fertility clinics, biobanking companies and cryopreservation technology providers, all of which are helping to usher in a new age with AI-driven embryo selection techniques and rapid freezing.
Market Share Analysis by Company
| Company Name | Estimated Market Share (%) |
|---|---|
| Vitrolife AB | 18-22% |
| Merck KGaA (Sigma-Aldrich) | 12-16% |
| CooperSurgical, Inc. | 10-14% |
| Cryoport, Inc. | 8-12% |
| Kitazato Corporation | 6-10% |
| Other Companies (combined) | 30-40% |
| Company Name | Key Offerings/Activities |
|---|---|
| Vitrolife AB | Develops high-survivability cryopreservation media, vitrification kits, and embryo storage solutions. |
| Merck KGaA (Sigma-Aldrich) | Specializes in cryoprotectants, cell culture media, and IVF freezing solutions for embryo and oocyte preservation. |
| CooperSurgical, Inc. | Manufactures vitrification devices, cryogenic storage tanks, and AI-driven IVF lab automation. |
| Cryoport, Inc. | Provides cryogenic shipping and storage solutions for reproductive cells, embryos, and tissues. |
| Kitazato Corporation | Focuses on closed-system vitrification, high-recovery embryo freezing kits, and IVF lab innovations. |
Key Company Insights
Vitrolife AB (18-22%)
Vitrolife is a global leader in IVF cryopreservation, offering advanced vitrification kits, embryo storage solutions, and specialized cryoprotectants to improve post-thaw viability and pregnancy success rates.
Merck KGaA (Sigma-Aldrich) (12-16%)
Merck provides pharmaceutical-grade cryopreservation media, ensuring optimal embryo and oocyte survival through specialized freezing solutions.
CooperSurgical, Inc. (10-14%)
CooperSurgical specializes in state-of-the-art IVF cryogenic storage systems, integrating automated embryo monitoring and AI-driven selection tools.
Cryoport, Inc. (8-12%)
Cryoport offers specialized cryogenic transport and storage systems, ensuring secure, long-term fertility preservation for IVF patients worldwide.
Kitazato Corporation (6-10%)
Kitazato focuses on closed-system vitrification, reducing contamination risks and ensuring high survival rates for frozen embryos and eggs.
Other Key Players (30-40% Combined)
Several biotechnology firms, fertility service providers, and medical device manufacturers contribute to advancements in cryopreservation media, AI-enhanced fertility solutions, and long-term reproductive cell storage. These include:
The overall market size for the Cryopreservation for In-Vitro Fertilization (IVF) Market was USD 564.4 Million in 2025.
The Cryopreservation for In-Vitro Fertilization (IVF) Market is expected to reach USD 1,477.2 Million in 2035
Rising infertility rates, increasing adoption of fertility preservation techniques, advancements in cryopreservation technology, and growing awareness of IVF treatments will drive market growth.
The USA, China, India, Germany, and Japan are key contributors.
Oocyte cryopreservation is expected to dominate due to increasing demand for egg freezing as a fertility preservation option.
Cryopreservation for In-vitro Fertilization (IVF) Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
